Skip to main content
Ruby Gupta, MD, Oncology, Dearborn, MI

Ruby Gupta MD

Hematologic Oncology


Hematology and oncology fellow at William Beaumont hospital

Join to View Full Profile
  • 4700 Schaefer RdSte 260Dearborn, MI 48126

  • Phone+1 313-583-5400

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Corewell Health William Beaumont University Hospital
    Corewell Health William Beaumont University HospitalFellowship, Hematology and Medical Oncology, 2019 - 2022
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2018 - 2019
  • George Washington University
    George Washington UniversityResidency, Internal Medicine, 2011 - 2014
  • Morehouse School of Medicine
    Morehouse School of MedicineResidency, Psychiatry, 2009 - 2011
  • Government Medical College Nagpur
    Government Medical College NagpurClass of 2005

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2022 - 2028
  • OH State Medical License
    OH State Medical License 2018 - 2021
  • PA State Medical License
    PA State Medical License 2014 - 2018
  • DC State Medical License
    DC State Medical License 2012 - 2014
  • Hematology
    American Board of Internal Medicine Hematology
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Phase I/II study evaluating the safety and clinical efficacy of temsirolimus and bevacizumab in patients with chemotherapy refractory metastatic castration-resistant p...  
    • Pedro Barata, Matthew Cooney, Prateek Mendiratta, Ruby Gupta, Robert Dreice, Jorge A. Garcia, Investigational New Drugs, 11/7/2018
  • The impact of microsatellite stability status in colorectal cancer  
    Ruby gupta, Surajit Sinha, Rabindra Paul, Current problems in cancer
  • Streptococcus pneumoniae Antigen, Missing Opportunities of a Promising Point of Care Diagnostic Test  
    Magdelina Slomka, Ruby Gupta et al, University of Louisville journal of respiratory infections

Abstracts/Posters

  • Treatment of Metastatic Non clear cell Renal Cell Carcinoma (nccRCC) with Ipilimumab plus Nivolumab (Ipi/Nivo).
    • Ruby Gupta, Moshe Ornstein, Anita Gul, et al, GU ASCO 2019, San Francisco
  • . Impact of the USPSTF Recommendations on Prostate Cancer Stage Migration and De-novo Metastatic Prostate Cancer
    • Yu-Wei Chen, Ruby Gupta, Moshe Ornstein, et al, GU ASCO, San Francisco
  • Oncoyeasti: a web-based application to translate data obtained from yeast high-throughput drug screens into cancer therapeutics
    Ruby Gupta et al, Molecular cancer therapeutics

Lectures

  • Clinical activity of ipilimumab plus nivolumab (Ipi/Nivo) in patients (pts) with metastatic non-clear cell renal cell carcinoma (nccRCC). 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • CT University, Fortis Hospital Sign MoU
    CT University, Fortis Hospital Sign MoUJanuary 2nd, 2018

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: